Board Meeting5 May 2026, 03:51 pm
JB Chemicals Board to Consider FY26 Results & Dividend
AI Summary
JB Chemicals & Pharmaceuticals Ltd has scheduled a Board of Directors meeting on May 11, 2026, to consider and approve the standalone and consolidated audited financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a final dividend on equity shares for FY 2025-26, subject to shareholder approval.
Key Highlights
- Board meeting scheduled for May 11, 2026.
- To approve FY26 standalone and consolidated audited financial results.
- Consideration of final dividend for FY26.
- Dividend recommendation subject to shareholder approval.
Price Impact
More from JBCHEPHARM